Fibroblastic rheumatism.
Marconi IM, Rivitti-Machado MC, Sotto MN, Nico MM.
Clin Exp Dermatol. 2009 Jan;34(1):29-32. doi: 10.1111/j.1365-2230.2008.02748.x.
Fibroblastic rheumatism: an uncommon arthritis. A case-based review.
Pieta A, Zioga A, Skalkou A, Venetsanopoulou AI, Drosos AA, Voulgari PV.
Rheumatol Int. 2022 Jun;42(6):1097-1103. doi: 10.1007/s00296-021-05004-0. Epub 2021 Oct 5.
Fibroblastic rheumatism: a diagnostic challenge.
Paolino G, Stabile G, Guida S, Rongioletti F.
Ital J Dermatol Venerol. 2024 Feb;159(1):74-75. doi: 10.23736/S2784-8671.23.07724-1. Epub 2024 Jan 10.
Fibroblastic rheumatism.
du Toit R, Schneider JW, Whitelaw DA.
J Clin Rheumatol. 2006 Aug;12(4):201-3. doi: 10.1097/01.rhu.0000231383.50323.b5.
Fibroblastic rheumatism.
Kanzler MH, Dhillon I, Headington JT.
Arch Dermatol. 1995 Jun;131(6):710-2.
Fibroblast pathology in inflammatory diseases.
Wei K, Nguyen HN, Brenner MB.
J Clin Invest. 2021 Oct 15;131(20):e149538. doi: 10.1172/JCI149538.
Multicentric reticulohistiocytosis and fibroblastic rheumatism.
Trotta F, Colina M.
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):543-57. doi: 10.1016/j.berh.2012.07.006.
Fibroblastic rheumatism.
Ostlere LS, Stevens HP, Jarmulowicz M, Higgens C, Black C, Rustin MH.
Clin Exp Dermatol. 1994 May;19(3):268-70. doi: 10.1111/j.1365-2230.1994.tb01185.x.
Fibroblastic rheumatism: case report and review of the literature.
Lee JM, Sundel RP, Liang MG.
Pediatr Dermatol. 2002 Nov-Dec;19(6):532-5. doi: 10.1046/j.1525-1470.2002.00227.x.
Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions.
Komatsu N, Takayanagi H.
Nat Rev Rheumatol. 2022 Jul;18(7):415-429. doi: 10.1038/s41584-022-00793-5. Epub 2022 Jun 15.
